CClinicalTrials.gg
Status unknownNCT02649400Updated Jan 12, 2016

Assessment of Functional Capacity and Inflammatory Markers in Women With Heart Failure With Preserved Ejection Fraction

An observational study in Heart Failure, Diastolic, Coronary Artery Disease and Inflammation, sponsored by Federal University of São Paulo. Status unknown at 1 site in Brazil. Open to female participants aged 35 Years to 70 Years. Per ClinicalTrials.gov, last updated 2016-01-12.

Sponsored by Federal University of São Paulo · Observational

The sponsor has not verified this record recently (last verified Jan 2016), so the status shown — last known as Active, not recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
50
Ages
35 Years to 70 Years
Sex
Female
01

Study summary

This study assesses the impact of diastolic heart failure on exercise capacity in women who have a previous coronary condition. All the participants will go through the same evaluation.

Read the detailed description

It is well established that systolic heart failure impacts exercise capacity and quality of life, diastolic heart failure however, is not well documented as a condition that reduces physical performance.

To confirm that patients have a diastolic disfunction an echocardiography will be performed, this will also yield the left ventricle ejection fraction to confirm the preserved ejection fraction heart failure diagnostics.

Exercise capacity will be assessed using the distance walked on the six-minute walking test, performed on a 30m corridor.

Pulmonary function will be assessed with spirometry and values of forced vital capacity and forced expired volume in one second will be recorded and compared to the age-predicted values.

Respiratory strength will be determined by maximal pressure achieved on a respiratory manometer.

Peripheral muscular strength will be assessed with a handheld dynamometer. Knee extension strength of the dominant leg will be recorded.

An echocardiography will be performed to assess systolic and diastolic function and ejection fraction.

Heart autonomic function will be evaluated using a heart rate monitor and a computer software to identify the sympathovagal balance.

02

Conditions studied

03

In context

Heart Failure

5,701 studies on the registry are indexed under Heart Failure; 1,220 are open to participants now.

This study's enrollment of 50 is below the median of 200 across 1,679 observational studies indexed under Heart Failure.

Browse Heart Failure studies →

Lead sponsor

Federal University of São Paulo is the lead sponsor of 427 studies on the registry; 22 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
35 Years to 70 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Women with coronary artery disease diagnosed through angiography and heart failure with preserved ejection fraction diagnosed via ecocardiography.

Inclusion criteria

  • Women;
  • Aged between 35 and 70 years;
  • Coronary artery disease proven by coronary angiography;
  • Diastolic heart failure confirmed by recent echocardiography (6 months);
  • Left Ventricle ejection fraction of greater than 50%;
  • Absence of acute or chronic pulmonary disease;
  • Patient clinically compensated;
  • Consent form signed for participation in the research

Exclusion criteria

Exclusion Criteria:

  • Inability to perform spirometry;
  • Presence of acute or chronic pulmonary disease;
  • Chronic inflammatory disease, kidney or liver disease;
  • Patients using corticosteroids, aspirin or other nonsteroidal anti-inflammatory;
  • Clinical or laboratory evidence of infection;
  • Morbid obesity;
  • Hemodynamic instability at the time of spirometry;
  • Patient's or legal guardian request to leave at any time of the study.
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
50 participants (actual)
Patient registry
No
Biospecimen retention
Samples with dna

Groups and cohorts

  • Diastolic Heart Failure

    Women with diastolic heart failure and previous coronary artery disease

06

What researchers measure

Primary outcomes

  1. Functional Capacity

    Measured by the distance walked in the six-minute walking test in meters.

    Time frame: Up to 1 year after diagnosis

  2. Inflammatory markers

    Inflammatory markers evaluated using specific assays for blood analysis Interleukin (IL) 1 (pg/mL), IL-6 (pg/mL), IL 8 (pg/mL),Tumor Necrosis Factor alpha (pg/mL), Brain Natriuretic Peptide (BNP) (pg/mL), pro-BNP (pg/mL); Lab results will be analysed for each marker and values will be compared to laboratory reference data to identify values out of range.

    Time frame: Up to 1 year after diagnosis on the same day as functional capacity assessment

  3. Inflammatory Markers

    Inflammatory markers evaluated using specific assays for blood analysis for high sensitivity C reactive protein (mg/L), alpha-1-acid glycoprotein (mg/dL) and platelets (platelets/cubic millimeters), lactate (mg/dL), uric acid (mg/dL)

    Time frame: Up to 1 year after diagnosis on the same day as functional capacity assessment

Secondary outcomes

  1. Heart autonomic function

    Sympathovagal balance assessed by heart rate variability using a heart monitor

    Time frame: Up to 1 year after diagnosis on the same day as functional capacity assessment

  2. Quality of life

    Quality of life assessed by the Minnesota questionnaire specific for heart failure

    Time frame: Up to 1 year after diagnosis on the same day as functional capacity assessment

  3. Pulmonary function

    Pulmonary function assessed by spirometry for obtaining values of forced expired volume in one second (FEV1), forced vital capacity (FVC) and FEV1/FVC ratio

    Time frame: Up to 1 year after diagnosis on the same day as functional capacity assessment

  4. Respiratory muscle strength

    Respiratory muscle strength assessed by manometer for obtaining maximal inspiratory pressure and maximal expiratory pressure values in cmH2O.

    Time frame: Up to 1 year after diagnosis on the same day as functional capacity assessment

  5. Peripheral muscle strength

    Peripheral muscle strength assessed by the quadriceps strength using a portable dynamometer in kilogram-force (kgf)

    Time frame: Up to 1 year after diagnosis on the same day as functional capacity assessment

07

Study locations

1 site
  • Federal University of Sao Paulo
    Sao Paulo, 04024002, Brazil
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 12, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02649400
Lead sponsor
Federal University of São Paulo
Responsible party
Daniel Figueiredo Alves da Silva (Post-graduate Student, Federal University of São Paulo) — Principal investigator
First posted
Jan 7, 2016
Start date
Aug 2013
Primary completion
Aug 2014
Last update
Jan 12, 2016

Study contacts

Daniel Figueiredo Alves da Silva, PT
principal investigator · Federal University of São Paulo

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jan 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion